[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100635150":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":15,"centralContacts":20,"locations":26,"responsibleParty":42,"collaborators":7,"id":44,"slug":7,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":45,"sex":51,"minAge":52,"maxAge":7,"enrollmentInfo":53,"targetDuration":7,"studyType":56,"phases":7,"briefSummary":57,"conditions":58,"keywords":62,"overallStatus":28,"whyStopped":7,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Okuvision GmbH","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":13},"DEVICE","Transcorneal Electrical Stimulation using the OkuStim System","Single application of the OkuStim® System for TES therapy in accordance with its intended purpose for 30 minutes.\n\nNo control or comparative intervention planned.",[14],"OkuStim",[16],{"name":17,"affiliation":18,"role":19},"Dr. med. Svenja Deuchler","Augenzentrum Frankfurt Prof. Koch GmbH","PRINCIPAL_INVESTIGATOR",[21],{"name":22,"role":23,"phone":24,"phoneExt":7,"email":25},"Claudia Büdel","CONTACT","+49 69 7566 8880","info@azffm.de",[27],{"facility":18,"status":28,"city":29,"state":7,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"RECRUITING","Frankfurt am Main","60549","Germany","DE",{"type":34,"coordinates":35},"Point",[36,37],8.68417,50.11552,{"lat":37,"lon":36},[40,41],{"name":22,"role":23,"phone":24,"phoneExt":7,"email":25},{"name":17,"role":19,"phone":7,"phoneExt":7,"email":7},{"type":43,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100635150",false,"NCT07548944","Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance","Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation (TES) on Visual Performance in Patients With Retinitis Pigmentosa and Similar Retinal Diseases","TES-STEP","Inclusion Criteria:\n\n* Adult patients (≥ 18 years) with clinically diagnosed retinitis pigmentosa (RP) or other similar degenerative retinal disease\n* Current treatment with TES using the OkuStim® System within the intended purpose\n* Subjective perception of short-term effects after TES treatment\n* Ability and willingness to give informed consent\n\nExclusion Criteria:\n\n* Cognitive, psychological, or linguistic limitations that prevent informed consent or proper study participation\n* Presence of other eye diseases (e.g., cataract, glaucoma, macular degeneration) that, in the opinion of the investigator, compromise or confound study assessments\n* Simultaneous participation in other clinical studies that could influence the results of the study\n* Severe comorbidities that could compromise patient safety or study conduct","ALL","18 Years",{"count":54,"type":55},30,"ESTIMATED","OBSERVATIONAL","Retinitis pigmentosa and similar degenerative diseases of the retina lead to progressive loss of vision. TES therapy with the CE-marked OkuStim® System is a treatment approved in the EU for slowing the progression of the disease. Patients increasingly report short-term subjective improvements in vision, which have not yet been systematically investigated. This exploratory study is conducted to determine whether these subjective short-term effects can be measured, and therefore also be quantified, by objective tests.",[59,60,61],"Retinitis Pigmentosa (RP)","Usher Syndrome","Cone Rod Dystrophy",[63,64,14,65,66,67,68,69,70],"Transcorneal Electrical Stimulation","TES","Okuvision","Retinitis pigmentosa","Eye Diseases","Retinal Dystrophies","Retinal Degeneration","Retinal Diseases","2026-04-30",{"date":73,"type":74},"2026-05-01","ACTUAL",{"date":76,"type":74},"2026-04-20",{"date":78,"type":55},"2027-03",{"name":5,"class":6},1]